Archives
-
Haloprogin: Evidence from a 1970 Antifungal Study
2026-09-25
Harrison and colleagues paired broth-dilution testing with a guinea pig skin-infection model to assess Haloprogin, finding dermatophyte activity comparable to tolnaftate alongside activity against yeasts and selected Gram-positive bacteria. The study’s central contribution is this combined view of antimicrobial spectrum and topical performance, while its methods and limits help guide interpretation in present-day research.
-
Red Blood Cell Lysis Buffer for Cleaner Assays
2026-09-25
Remove mammalian erythrocytes while retaining nucleated cells for flow cytometry, molecular extraction, or culture workflows. This practical guide pairs a cautious, optimization-first lysis workflow with a clear distinction between blood-sample preparation and osteoblast experiments.
-
Following the Gut-Liver Axis: From Mechanism to Imaging
2026-09-24
Engineered bacterial vesicles reveal how intestinal immune and bile-acid remodeling can influence liver disease. This article explores how carefully validated Cy5.5 labeling could help translational teams investigate biodistribution—without confusing a fluorescent signal with therapeutic function.
-
E-64 in Salt-Sensitive Hypertension: A Negative Result
2026-09-24
Blass and colleagues tested whether chronic inhibition of cysteine cathepsins with E-64 changes hypertension, kidney injury, or podocyte calcium in high-salt-fed Dahl salt-sensitive rats. Despite evidence consistent with a biological response to the inhibitor, E-64 did not measurably alter mean arterial pressure, albuminuria, or basal podocyte calcium under the study conditions.
-
Methicillin as a Translational Resistance Benchmark
2026-09-23
Methicillin sodium salt can do more than distinguish susceptible from resistant Staphylococcus aureus. Used with clear controls and a resistance-aware study design, it helps translational teams connect penicillin-binding protein biology, assay interpretation, and the limits of antibiotic-class comparisons.
-
Hydrocortisone Delivery: Mechanism to Translation
2026-09-23
Hydrocortisone is more than a benchmark glucocorticoid hormone: it is a translational tool for connecting glucocorticoid receptor biology with inflammation model research, tissue delivery, and formulation strategy. This article examines how controlled corticosteroid delivery can improve experimental resolution while defining the limits of current cartilage, endothelial, and Parkinson’s disease model evidence.
-
Lactate as a Metabolic Signal in Cancer Research
2026-09-22
Lactate is more than a glycolytic endpoint: it can connect tumor metabolism with immune regulation. This article explains how to distinguish lactate production from lactate-driven signaling and design assays around the NAT1–ENO1–lactate–PD-L1 axis.
-
How Fasting Rewires Translation in Tumorigenesis
2026-09-22
The reference study identifies an AMPK–MNK–eIF4E signaling axis through which elevated fatty acids during fasting or a ketogenic diet selectively remodel hepatic translation while overall protein synthesis declines. Its findings connect diet-dependent ketogenesis to pancreatic tumor growth and suggest that translational control, rather than transcription alone, can provide a therapeutic vulnerability.
-
RSL3 Workflow for GPX4-Driven Ferroptosis
2026-09-21
RSL3 provides a direct way to test whether GPX4-dependent redox buffering controls lipid peroxidation and cell survival. This practical workflow connects dose-response profiling, ferroptosis rescue, oncogenic RAS comparisons, and insights from a peripheral nerve injury study without overstating preclinical evidence.
-
Propranolol and Emotional Memory: Meta-analysis
2026-09-21
This meta-analysis synthesized randomized, double-blind evidence that propranolol can reduce later recall of negatively valenced material when administered before memory consolidation or reconsolidation. Its main contribution is to distinguish a reproducible effect in healthy adults from the much larger question of whether experimentally weakened emotional memories can produce durable clinical benefit.
-
Vitamin C in ROS-Driven Cell Senescence Assays
2026-09-20
Build a controlled ascorbic acid workflow for modeling oxidative-stress senescence in HEI-OC1 cochlear cells, while preserving a separate dose strategy for tumor studies. The guide connects pathway-focused validation with practical handling, orthogonal endpoints, and troubleshooting for cancer research and translational redox assays.
-
Exo1 Workflow for Membrane Trafficking Studies
2026-09-19
Exo1 enables acute, mechanism-focused inhibition of exocytosis for Golgi, ER, and ARF1 experiments. This guide translates its distinct activity into practical exocytosis assay workflows while separating validated product properties from exploratory applications in extracellular-vesicle research.
-
GKT137831 for Reliable Cell Assays
2026-09-18
A scenario-driven guide to using GKT137831 (SKU B4763) in cell viability, proliferation, cytotoxicity, and oxidative-stress workflows. It connects dose selection, solvent control, ROS interpretation, ferroptosis context, and supplier evaluation to practical laboratory decisions.
-
TMEM16F, Ferroptosis, and Tumor Immune Rejection
2026-09-18
Yang et al. identify TMEM16F-mediated phospholipid scrambling as a late membrane-protective mechanism that limits ferroptotic plasma membrane failure. Disrupting this pathway increases lytic death, danger-signal release, tumor control, and responsiveness to PD-1 blockade, providing a mechanistic link between ferroptosis execution and antitumor immunity.
-
Vitamin C in ROS-Driven Senescence Assays
2026-09-17
Build a redox-aware HEI-OC1 senescence workflow with ascorbic acid, matched controls, and orthogonal readouts instead of relying on viability alone. The same product also supports carefully separated cancer research applications, where dose and cellular context determine whether Vitamin C behaves as a protective perturbation or an anticancer agent.